Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-383P is a human pseudogene derived from the U6 small nuclear RNA (snRNA) gene family[2]. U6 snRNA is an essential component of the spliceosome, playing a critical role in nuclear pre-mRNA splicing in eukaryotes[1][3]. However, pseudogenes such as RNU6-383P typically do not encode functional RNA molecules or proteins due to accumulated mutations or lack of functional promoters, and thus are considered non-functional genomic elements[4]. Some pseudogene-derived transcripts can act as long non-coding RNAs with regulatory functions, but there is currently no evidence that RNU6-383P produces a functional transcript or has a direct biological or disease relevance[2][4][6]. It is not considered a therapeutic target.\n\nKey context:\n- RNU6-383P is not a protein, receptor, enzyme, or other classical druggable target.\n- Pseudogenes rarely encode active products, although transcribed pseudogenes in other gene families can sometimes modulate gene expression as competitive endogenous RNAs (ceRNAs) or miRNA sponges[4][6]. There is no evidence for this for RNU6-383P at present.\n- The entry is not misspelled nor incorrect, but as a pseudogene, it falls outside categories of canonical therapeutic targets.\n\nIf a more structured entry or evidence of function is needed, additional up-to-date transcriptomic or functional studies specific to RNU6-383P would be required.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 383, pseudogene (RNU6-383P).